Similar articles

• Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.

  Serby M, Angrist B, Lieberman A. Serby M, et al. Am J Psychiatry. 1978 Oct;135(10):1227-9. doi: 10.1176/ajp.135.10.1227. Am J Psychiatry. 1978. PMID: 29497 No abstract available.
• Comparison between lergotrile and bromocriptine in parkinsonism.

  Teychenne PF, Pfeiffer RF, Bern SM, McInturff D, Calne DB. Teychenne PF, et al. Ann Neurol. 1978 Apr;3(4):319-24. doi: 10.1002/ana.410030408. Ann Neurol. 1978. PMID: 666273
• [Neuropsychic side effects of bromocriptine in Parkinson's disease].

  Simonetta M, Schmitt L, Montastruc JL, Rascol A. Simonetta M, et al. Rev Neurol (Paris). 1987;143(8-9):608-11. Rev Neurol (Paris). 1987. PMID: 3671965 French.
• Treatment of Parkinson's disease with dopamine agonists: a review.

  Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Lieberman A, et al. Am J Med Sci. 1979 Jul-Aug;278(1):65-76. doi: 10.1097/00000441-197907000-00008. Am J Med Sci. 1979. PMID: 39452 Review.
• Bromocriptine in the treatment of parkinsonism.

  Parkes JD. Parkes JD. Drugs. 1979 May;17(5):365-82. doi: 10.2165/00003495-197917050-00006. Drugs. 1979. PMID: 37066 Review.